These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 1290306

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Phosphodiesterase-inhibiting properties of newer inotropic agents.
    Scholz H, Meyer W.
    Circulation; 1986 Mar; 73(3 Pt 2):III99-108. PubMed ID: 2417748
    [Abstract] [Full Text] [Related]

  • 24. Force-frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance.
    Endoh M.
    Eur J Pharmacol; 2004 Oct 01; 500(1-3):73-86. PubMed ID: 15464022
    [Abstract] [Full Text] [Related]

  • 25. Longer term effects of ouabain on the contractility of rat isolated cardiomyocytes and on the expression of Ca and Na regulating proteins.
    Müller-Ehmsen J, Nickel J, Zobel C, Hirsch I, Bölck B, Brixius K, Schwinger RH.
    Basic Res Cardiol; 2003 Mar 01; 98(2):90-6. PubMed ID: 12607130
    [Abstract] [Full Text] [Related]

  • 26. In-vivo effects of amrinone and milrinone on left ventricular dP/dt, intraventricular pressure and heart rate in pentobarbital-anesthetized guinea pigs.
    Lin BB, Chen HL.
    Res Commun Chem Pathol Pharmacol; 1991 Nov 01; 74(2):237-40. PubMed ID: 1811284
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. 3-Chlorodiphenylamine activates cardiac troponin by a mechanism distinct from bepridil or TFP.
    Tikunova SB, Cuesta A, Price M, Li MX, Belevych N, Biesiadecki BJ, Reiser PJ, Hwang PM, Davis JP.
    J Gen Physiol; 2019 Jan 07; 151(1):9-17. PubMed ID: 30442775
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Ca2+ sensitizers: An emerging class of agents for counterbalancing weakness in skeletal muscle diseases?
    Ochala J.
    Neuromuscul Disord; 2010 Feb 07; 20(2):98-101. PubMed ID: 20006502
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Interaction of cardiac troponin with cardiotonic drugs: a structural perspective.
    Li MX, Robertson IM, Sykes BD.
    Biochem Biophys Res Commun; 2008 Apr 25; 369(1):88-99. PubMed ID: 18162171
    [Abstract] [Full Text] [Related]

  • 39. Characterization of the Ca2+-switch in skeletal and cardiac muscles.
    Babu A, Lehman W, Gulati J.
    FEBS Lett; 1989 Jul 17; 251(1-2):177-82. PubMed ID: 2753157
    [Abstract] [Full Text] [Related]

  • 40. [The effect of various low molecular weight compounds on the cation-binding properties of troponin with the heart].
    Geguchadze RN, Gusev NB.
    Biokhimiia; 1991 Apr 17; 56(4):753-60. PubMed ID: 1912077
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.